Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Which company should be worth more? A or B?

<< Previous

Bullboard Posts

Next >>

Post by TH1902on Aug 05, 2022 6:50pm

214 Views

Post# 34875531

Which company should be worth more? A or B?

When will THERA reward its long and (stupidly) faithful shareholders ? What a terrible chart...and volume is abysmal...wow...

What magic tricks will IR do to give us a 200% lift in one month like CYDY? Why do we not have as many investors and eyes on our stock the way CYDY does?

Maybe time to change the approach in the market and be more promotional? Thoughts?